Sanara MedTech EBITDA 2014-2025 | SMTI
Sanara MedTech ebitda from 2014 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Sanara MedTech Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $-1 |
| 2022 | $-10 |
| 2021 | $-7 |
| 2020 | $-5 |
| 2019 | $-3 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $-1 |
| 2014 | $-2 |
| 2013 | $-2 |
|
Sanara MedTech Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $4 |
| 2025-06-30 | $1 |
| 2025-03-31 | $-1 |
| 2024-12-31 | $-1 |
| 2024-09-30 | $2 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $0 |
| 2023-12-31 | $1 |
| 2023-09-30 | $0 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $0 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-1 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.194B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |